SCHEMBL30516503

SCHEMBL30516503

O=c1[nH]c2ccc(-c3cccnc3)cc2[nH]c1=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 1/20 0.54
QPCT Q16769 1/20 0.53
QPCTL Q9NXS2 1/20 0.53
PDE3B Q13370 2/20 0.51
PDE3A Q14432 2/20 0.51
GRIK1 P39086 2/20 0.51
CYP1A2 P05177 4/20 0.50
CYP3A4 P08684 2/20 0.50
ALDH1A1 P00352 1/20 0.50
CYP2A6 P11509 1/20 0.50
CYP2C9 P11712 2/20 0.49
PTGES O14684 1/20 0.49
CYP2C19 P33261 1/20 0.49
CYP11B1 P15538 6/20 0.49
CYP11B2 P19099 6/20 0.49
GRIN2D O15399 1/20 0.49
GRIN3B O60391 1/20 0.49
GRIN1 Q05586 1/20 0.49
GRIN2A Q12879 1/20 0.49
GRIN2B Q13224 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30832786 0.90 PDE3B (0.65) FGFR1QPCTQPCTLPDE3BPDE3A
SCHEMBL1884345 0.90 PDE3B (0.65) FGFR1QPCTQPCTLPDE3BPDE3A
SCHEMBL7270901 0.79 CYP11B1 (0.52) FGFR1CYP1A2CYP3A4CYP2C9PTGES
SCHEMBL7273923 0.79 AURKA (0.56) FGFR1CYP3A4CYP2C9PTGESCYP2C19
SCHEMBL31441275 0.78 PRMT5 (0.52) FGFR1QPCTQPCTLPDE3BPDE3A
SCHEMBL17067225 0.78 FGFR1 (0.59) FGFR1QPCTQPCTLPDE3BPDE3A
SCHEMBL16284624 0.77 TLR8 (0.59) FGFR1QPCTQPCTLCYP1A2CYP3A4
SCHEMBL4287824 0.76 CYP11B2 (0.57) FGFR1PDE3BPDE3ACYP11B1CYP11B2
SCHEMBL30494348 0.76 PDE3B (0.70) FGFR1QPCTQPCTLPDE3BPDE3A
SCHEMBL6909727 0.76 PDE3B (0.68) FGFR1QPCTQPCTLPDE3BPDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116528867-A Compounds for the treatment of Alzheimer's disease 艾伯塔大学理事会 2023-08-01 CN disclosed